Blog Archives

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial (2018)

Type of publication: Randomised controlled trial Author(s): Iveson TJ, Kerr RS, Saunders MP, Cassidy J, Hollander NH, Tabernero J, Haydon A, Glimelius B, Harkin A, Allan K, McQueen J, Scudder C, Boyd KA, Briggs A, Waterston A, Medley L, Wilson

Posted in Staff Publication Tagged with: , ,

Protein biomarkers in the rectal mucosa: a novel test for colorectal cancer? (2015)

Type of publication: Conference abstract Author(s): *Lacy-Colson J., Norwood M., Murray C., Booth J. Citation: Gut, June 2015, vol./is. 64/(A529-A530) Abstract: Introduction: Earlier detection of colorectal cancer is a clinical priority. Currently very high numbers of patients are referred for

Posted in Staff Publication Tagged with: , ,

Does compliance with the 2 week wait colorectal cancer referral system lead to a higher cancer detection rate? (2014)

Type of publication: Conference abstract Author(s): *Kaur P., *Cheetham M., *McCloud J. Citation: Colorectal Disease, July 2014, vol./is. 16/(73), 1462-8910 (July 2014) Abstract: Background: Current guidelines suggest that patients with a suspected colorectal cancer are seen within 2 weeks of

Posted in Staff Publication Tagged with: , ,

Incidence of metachronous colorectal tumours at one year surveillance colonoscopy (2014)

Type of publication: Conference abstract Author(s): *Bajwa A., *McConnell C., *Odulaja M., *Chandra A., *Luke D., *Cheetham M. Citation: Colorectal Disease, September 2014, vol./is. 16/(59), 1462-8910 (September 2014) Abstract: Aim: The National Institution for health and care excellence (of United

Posted in Staff Publication Tagged with: , ,